SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-001660
Filing Date
2024-02-14
Accepted
2024-02-14 16:01:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 ICOSAVAX, INC. p24-0799sc13g.htm SC 13G 61789
2 JOINT ACQUISITION STATEMENT p24-0799exhibit99.htm EX-99.1 4486
  Complete submission text file 0000902664-24-001660.txt   67833
Mailing Address 1001 10TH AVENUE SOUTH SUITE 216 NAPLES FL 34102
Business Address 1001 10TH AVENUE SOUTH SUITE 216 NAPLES FL 34102 239-384-9750
Pentwater Capital Management LP (Filed by) CIK: 0001425851 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92771 | Film No.: 24637472
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)